is glp-1 patented How Compounded GLP-1s Are Challenging Big Pharma and Drug Patents pharmaindustry #glp1 #patentcliff #obesitytreatment #diabetescare

Ucn2 administration also suppresses food intake as well as resulting in delayed gastric emptying, and decreased heat-induced edema

This means that 67 people with (severe) cardiovascular risk need to be on Wegovy consistently to avoid one cardiovascular event, for example, a heart attack

This pattern will likely be reproduced with future high-demand therapies, forcing regulators, manufacturers, and clinicians to balance access, safety, and incentives for innovation as more care moves outside traditional clinical settings and insurer-mediated systems.

If you are experiencing persistent or concerning cold sensitivity whilst taking Ozempic, it is advisable to discuss this with your GP or diabetes specialist nurse to rule out other underlying causes